|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
583911749 |
| 003 |
DE-627 |
| 005 |
20221017161715.0 |
| 007 |
tu |
| 008 |
081028s2009 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2008043678
|
| 016 |
7 |
|
|a b915453
|2 UK
|
| 020 |
|
|
|a 1420061143
|c (hbk.) : £109.00 hbk. : £109.00
|9 1-4200-6114-3
|
| 020 |
|
|
|a 9781420061147
|c : hardcover : alk. paper
|9 978-1-4200-6114-7
|
| 020 |
|
|
|a 9780367385736
|c pbk
|9 978-0-367-38573-6
|
| 035 |
|
|
|a (DE-627)583911749
|
| 035 |
|
|
|a (DE-576)305992252
|
| 035 |
|
|
|a (DE-599)GBV583911749
|
| 035 |
|
|
|a (OCoLC)637418941
|
| 035 |
|
|
|a (OCoLC)637418941
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a QP552.P4
|
| 060 |
|
0 |
|a QU 68
|
| 082 |
0 |
|
|a 612/.015756
|q LOC
|2 22
|
| 082 |
0 |
|
|a 612.015756
|
| 084 |
|
|
|a WD 5085
|2 rvk
|0 (DE-625)rvk/148192:
|
| 084 |
|
|
|a VK 8560
|2 rvk
|0 (DE-625)rvk/147540:253
|
| 245 |
1 |
0 |
|a Bioactive peptides
|c ed. by John Howl...
|
| 264 |
|
1 |
|a Boca Raton [u.a.]
|b CRC Press
|c [2009]
|
| 300 |
|
|
|a XV, 479 S.
|b Ill., graph. Darst., Kt
|c 27 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 505 |
8 |
0 |
|t Twenty-five years of galanin research
|r Johan Runesson ... [et al.]
|
| 505 |
8 |
0 |
|t Angiotensins : from endocrine to intracrine functions
|r Mark C. Chappell
|
| 505 |
8 |
0 |
|t Bioactive peptides in gut-brain signalling
|r Erik Näslund, Per Grybäck, and Per M. Hellström
|
| 505 |
8 |
0 |
|t Nonribosomal peptides
|r Alexandra A. Roberts, Leanne A. Pearson, and Brett A. Neilan
|
| 505 |
8 |
0 |
|t Anuran host-defense peptides that complex with Ca2+ calmodulin and inhibit the synthesis of the cell signalling agent nitric oxide by neuronal nitric oxide synthase
|r Jason R. Doyle ... [et al.]
|
| 505 |
8 |
0 |
|t Host-defense peptides from the secretion of the skin glands of frogs and toads : membrane-active peptides from the genera litoria, uperoleia, and crinia
|r John H. Bowie ... [et al.]
|
| 505 |
8 |
0 |
|t Antimicrobial peptides
|r Alison M. McDermott
|
| 505 |
8 |
0 |
|t Mast cell degranulating peptides
|r Joseph A. Price
|
| 505 |
8 |
0 |
|t Mastoparans
|r Sarah Jones and John Howl
|
| 505 |
8 |
0 |
|t Spider venom and hemolymph-derived cytolytic and antimicrobial peptides
|r Lucia Kuhn-Nentwig, Christian Trachsel, and Wolfgang Nentwig.
|
| 505 |
8 |
0 |
|t CT, CGRP, amylin, and adrenomedullins
|r Debbie L. Hay and David R. Poyner
|
| 505 |
8 |
0 |
|t Neuropeptide Y family peptides
|r Cláudia Cavadas, Joana Rosmaninho Salgado, and Eric Grouzmann
|
| 505 |
8 |
0 |
|t Pituitary adenylate cyclase-activating polypeptide
|r Eve M. Lutz ... [et al.]
|
| 505 |
8 |
0 |
|t Opioid peptides
|r Jane V. Aldrich
|
| 505 |
8 |
0 |
|t Cholecystokinins and gastrins
|r Jens F. Rehfeld
|
| 505 |
8 |
0 |
|t The chemistry and biology of insulin-like peptide 3, a novel member of the insulin superfamily
|r Fazel Shabanpoor ... [et al.]
|
| 505 |
8 |
0 |
|t Somatostatin analogues
|r Kjell Öberg
|
| 505 |
8 |
0 |
|t Tachykinins
|r Nigel M. Page, Parvathy Subramaniam, and Suzanne E. Newton
|
| 505 |
8 |
0 |
|t Neurotensin
|r Paul R. Dobner and Robert E. Carraway
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 2
|2 pdager
|
| 650 |
|
0 |
|a Peptides
|x Physiological effect
|
| 650 |
|
2 |
|a Peptides
|x physiology
|
| 650 |
|
2 |
|a Biological Factors
|x physiology
|
| 650 |
|
4 |
|a Peptides
|x Physiological effect
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4045125-2
|0 (DE-627)106202766
|0 (DE-576)209064005
|a Peptide
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4076388-2
|0 (DE-627)106083007
|0 (DE-576)209201738
|a Proteine
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4145589-7
|0 (DE-627)104105836
|0 (DE-576)209742593
|a Bioaktive Verbindungen
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Howl, John
|e herausgeberin
|4 edt
|
| 700 |
1 |
|
|a Jones, Sarah
|e herausgeberin
|4 edt
|
| 856 |
4 |
2 |
|u https://www.gbv.de/dms/bowker/toc/9780367385736.pdf
|m DE-601
|q pdf/application
|v 2020-01-19
|x Aggregator
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a ISIL_DE-27
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a ISIL_DE-3
|
| 912 |
|
|
|a GBV_ILN_65_a004
|
| 912 |
|
|
|a GBV_ILN_252
|
| 912 |
|
|
|a GBV_ILN_252_i133
|
| 912 |
|
|
|a GBV_ILN_2007
|
| 912 |
|
|
|a ISIL_DE-352
|
| 912 |
|
|
|a GBV_ILN_2015
|
| 912 |
|
|
|a ISIL_DE-93
|
| 935 |
|
|
|i Blocktest
|
| 936 |
r |
v |
|a WD 5085
|b Biologisch aktive Proteine (Flavine, Ferredoxine)
|k Biologie
|k Biophysik, Biochemie, Physiologische Chemie
|k Spezielle Biochemie und Biophysik
|k Biochemie und Biophysik organischer Verbindungen
|k Biologisch aktive Proteine (Flavine, Ferredoxine)
|0 (DE-627)1271759780
|0 (DE-625)rvk/148192:
|0 (DE-576)201759780
|
| 936 |
r |
v |
|a VK 8560
|b Allgemeines
|k Chemie und Pharmazie
|k Organische Chemie
|k Organische Chemie allgemein
|k Naturstoffe allgemein
|k Proteine; Aminosäuren; Amine
|k Allgemeines
|0 (DE-627)1271610825
|0 (DE-625)rvk/147540:253
|0 (DE-576)201610825
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 612/.015756
|
| 953 |
|
|
|2 045F
|a 612.015756
|
| 980 |
|
|
|2 31
|1 01
|x 0027
|b 117114816X
|c 00
|f J 36
|d BIO:EP:2000:How::2009
|e d
|j --%%--
|y z
|z 13-07-10
|
| 980 |
|
|
|2 65
|1 01
|x 3/4
|b 3541958960
|c 00
|f Ha 4
|d WD 5085 108<1,1>
|e u
|j --%%--
|k 1. paperback issue 2019
|y ka004
|z 23-12-19
|
| 980 |
|
|
|2 252
|1 01
|x 4252/133
|b 3599189587
|c 00
|f Ku1
|d RCHE/ VK 8560 H864 = B30685
|e s
|j --%%--
|k Regal Chemie Organische Chemie - Proteine, Peptide
|y zi133
|z 28-02-20
|
| 980 |
|
|
|2 2007
|1 01
|x DE-352
|b 322306351X
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 27-04-09
|
| 980 |
|
|
|2 2015
|1 01
|x DE-93
|b 3223063633
|c 00
|f --%%--
|d 5C 6825
|e --%%--
|j --%%--
|y l01
|z 08-11-11
|
| 982 |
|
|
|2 252
|1 01
|x 4252/133
|8 00
|a Aufsatzsammlung
|
| 982 |
|
|
|2 252
|1 01
|x 4252/133
|8 01
|a Peptide
|
| 982 |
|
|
|2 252
|1 01
|x 4252/133
|8 02
|a Bioaktive Verbindungen
|
| 983 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a BIO:EP:2000
|
| 983 |
|
|
|2 252
|1 01
|x 4252/133
|8 00
|a VK 8560
|
| 983 |
|
|
|2 252
|1 01
|x 4252/133
|8 01
|a WD 5250
|
| 984 |
|
|
|2 31
|1 01
|x 0027
|a 27$025490737
|
| 984 |
|
|
|2 65
|1 01
|x 3/4
|a 3/15$000489379
|
| 985 |
|
|
|2 31
|1 01
|x 0027
|a U405232
|
| 985 |
|
|
|2 65
|1 01
|x 3/4
|a 4/2020/00011
|
| 985 |
|
|
|2 252
|1 01
|x 4252/133
|a B30685
|
| 998 |
|
|
|2 31
|1 01
|x 0027
|a BIO 201009
|
| 998 |
|
|
|2 252
|1 01
|x 4252/133
|0 2020-02-28/1Neuerwerbung
|
| 998 |
|
|
|2 2015
|1 01
|x DE-93
|0 1111
|f 15
|
